Indonesia Neuraminidase Inhibitors Market (2025-2031) | Industry, Competitive Landscape, Outlook, Trends, Companies, Size & Revenue, Value, Segmentation, Growth, Forecast, Analysis, Share

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3.1 Indonesia Country Macro Economic Indicators

3.2 Indonesia Neuraminidase Inhibitors Market Revenues & Volume, 2021 & 2031F

3.3 Indonesia Neuraminidase Inhibitors Market - Industry Life Cycle

3.4 Indonesia Neuraminidase Inhibitors Market - Porter's Five Forces

3.5 Indonesia Neuraminidase Inhibitors Market Revenues & Volume Share, By Indication, 2021 & 2031F

3.6 Indonesia Neuraminidase Inhibitors Market Revenues & Volume Share, By Product, 2021 & 2031F

3.7 Indonesia Neuraminidase Inhibitors Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F

3.8 Indonesia Neuraminidase Inhibitors Market Revenues & Volume Share, By End User, 2021 & 2031F

3.9 Indonesia Neuraminidase Inhibitors Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing awareness about the importance of neuraminidase inhibitors in treating influenza in Indonesia

4.2.2 Rising prevalence of influenza cases in Indonesia

4.2.3 Government initiatives to promote the use of neuraminidase inhibitors in the country

4.3 Market Restraints

4.3.1 High cost associated with neuraminidase inhibitors leading to limited affordability for some patients

4.3.2 Limited access to healthcare facilities in rural areas, impacting the distribution and availability of neuraminidase inhibitors

6.1 Indonesia Neuraminidase Inhibitors Market, By Indication

6.1.1 Overview and Analysis

6.1.2 Indonesia Neuraminidase Inhibitors Market Revenues & Volume, By Indication, 2021- 2031F

6.1.3 Indonesia Neuraminidase Inhibitors Market Revenues & Volume, By Influenza Virus Type A, 2021- 2031F

6.1.4 Indonesia Neuraminidase Inhibitors Market Revenues & Volume, By Influenza Virus Type B, 2021- 2031F

6.1.5 Indonesia Neuraminidase Inhibitors Market Revenues & Volume, By Others, 2021- 2031F

6.2 Indonesia Neuraminidase Inhibitors Market, By Product

6.2.1 Overview and Analysis

6.2.2 Indonesia Neuraminidase Inhibitors Market Revenues & Volume, By Zanamivir, 2021- 2031F

6.2.3 Indonesia Neuraminidase Inhibitors Market Revenues & Volume, By Oseltamivir, 2021- 2031F

6.2.4 Indonesia Neuraminidase Inhibitors Market Revenues & Volume, By Peramivir, 2021- 2031F

6.2.5 Indonesia Neuraminidase Inhibitors Market Revenues & Volume, By Laninamivir, 2021- 2031F

6.2.6 Indonesia Neuraminidase Inhibitors Market Revenues & Volume, By Other, 2021- 2031F

6.3 Indonesia Neuraminidase Inhibitors Market, By Route of Administration

6.3.1 Overview and Analysis

6.3.2 Indonesia Neuraminidase Inhibitors Market Revenues & Volume, By Oral, 2021- 2031F

6.3.3 Indonesia Neuraminidase Inhibitors Market Revenues & Volume, By Inhalation, 2021- 2031F

6.3.4 Indonesia Neuraminidase Inhibitors Market Revenues & Volume, By Parenteral, 2021- 2031F

6.3.5 Indonesia Neuraminidase Inhibitors Market Revenues & Volume, By Others, 2021- 2031F

6.4 Indonesia Neuraminidase Inhibitors Market, By End User

6.4.1 Overview and Analysis

6.4.2 Indonesia Neuraminidase Inhibitors Market Revenues & Volume, By Hospitals, 2021- 2031F

6.4.3 Indonesia Neuraminidase Inhibitors Market Revenues & Volume, By Homecare, 2021- 2031F

6.4.4 Indonesia Neuraminidase Inhibitors Market Revenues & Volume, By Specialty Clinics, 2021- 2031F

6.4.5 Indonesia Neuraminidase Inhibitors Market Revenues & Volume, By Others, 2021- 2031F

6.5 Indonesia Neuraminidase Inhibitors Market, By Distribution Channel

6.5.1 Overview and Analysis

6.5.2 Indonesia Neuraminidase Inhibitors Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F

6.5.3 Indonesia Neuraminidase Inhibitors Market Revenues & Volume, By Online Pharmacy, 2021- 2031F

6.5.4 Indonesia Neuraminidase Inhibitors Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F

7.1 Indonesia Neuraminidase Inhibitors Market Export to Major Countries

7.2 Indonesia Neuraminidase Inhibitors Market Imports from Major Countries

8.1 Number of influenza cases reported annually in Indonesia

8.2 Percentage increase in prescriptions of neuraminidase inhibitors over the years

8.3 Rate of adoption of neuraminidase inhibitors in different regions of Indonesia

9.1 Indonesia Neuraminidase Inhibitors Market Opportunity Assessment, By Indication, 2021 & 2031F

9.2 Indonesia Neuraminidase Inhibitors Market Opportunity Assessment, By Product, 2021 & 2031F

9.3 Indonesia Neuraminidase Inhibitors Market Opportunity Assessment, By Route of Administration, 2021 & 2031F

9.4 Indonesia Neuraminidase Inhibitors Market Opportunity Assessment, By End User, 2021 & 2031F

9.5 Indonesia Neuraminidase Inhibitors Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F

10.1 Indonesia Neuraminidase Inhibitors Market Revenue Share, By Companies, 2024

10.2 Indonesia Neuraminidase Inhibitors Market Competitive Benchmarking, By Operating and Technical Parameters